http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0105131-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-46
filingDate 1983-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1987-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0105131-B1
titleOfInvention 2-(omega-alkylaminoalkyl)- and 2-(omega-dialkylaminoalkyl)-3-(4-x-benzylidene)-phthalimidines
abstract The 2-(ω-aikylaminoalkyl)- and 2-(m-dialkylaminoalkyl)-3-(4-X-benzylidene)phtalimidines are useful as local anesthetics.For the preparation, the adduct is formed between the suitable 3-(4-X-benzylidene)phtalide and a substituted aminoalkylamine, the adduct being then reacted with acetic anhydride; the X substituent at the position 4 of the benzylidene group then can be suitably converted according to the requirements.
priorityDate 1982-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247841
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226568912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID642371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236065799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226455370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236064125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID408285
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228895652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID678308
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228895650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID678307
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226460463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID909843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13136963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236067692

Total number of triples: 49.